Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



Long-term results of laser in situ keratomileusis for myopia

Ahu Yilmaz, Tolga Yilmaz, Feyza Altin.




Abstract

Laser in situ keratomileusis (LASIK) is still the most popular refractive surgery in the world. The aim of the study is to assess the long term clinical outcomes of LASIK in treating patients with different types of myopia. Pre- and postoperative distance visual acuity, refractive spherical equivalent (SE) and clinical examinations of dry eye disease were recorded. Values obtained at baseline and controls were compared with each other. While preoperative mean uncorrected distance visual acuity (UDVA) of low and moderate myopic patients was 0.1±0.07 on Snellen eye chart, and it was 0.86 ±0.11 at the 6th month and 0.92 ±0.05 at the 3rd year. At the last control examination, the percertages of manifest refractive SE in the range of ±0.50D and ±1.00D were 78.3%, 88.3%, respectively. The mean UDVA of high myopic patients was 0.03 ±0.02 preoperatively, and it was 0.84 ±0.16 at the 6th month and 0.69 ±0.21 at the 3rd year. UDVA at 3 years was significantly decreased compared with 6 month postoperatively.(p=0.01) At the last control examination of this group, the percentages of manifest refractive SE in the range of ±0.50D and ±1.00D were 48.3%, 66.1 %, respectively. These also decreased from 6 month to 3 years postoperatively.The mean tear break-up time and schirmer-1 values, which decreased in the postoperative first year visits of the patients, were close to the preoperative values at the last control. There were no statistically significant difference between the preoperative and 3rd year comparisons.(all p>0.05) In conclusion, LASIK is an effective and safe procedure in patient with myopia, preoperative higher SE is a predictor of low postoperative efficacy.

Key words: Cornea, Myopia, laser in situ keratomileusis, visual outcome, dry eye disease






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.